Skip to content

Clinical trials

Lung Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Russia Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20041
20062
20071
20083
20091
20103
20112
20124
20133
20142
20154
20164
20173
20183
20192
20204
20213
20222
20234
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Active, not recruiting9
Terminated7
Unknown status5
Recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Novartis Pharmaceuticals5
Bristol-Myers Squibb4
N.N. Petrov National Medical Research Center of Oncology3
Checkpoint Therapeutics, Inc.2
Eli Lilly and Company2
Incyte Corporation2
Merck Sharp & Dohme LLC2
Peregrine Pharmaceuticals2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms58
Carcinoma, Non-Small-Cell Lung33
Neoplasms12
Neoplasm Metastasis8
Melanoma6
Breast Neoplasms5
Adenocarcinoma of Lung4
Small Cell Lung Carcinoma4
Carcinoma3
Carcinoma, Renal Cell3

Trials

Showing 51 to 58 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.